Interview: António Portela, CEO, Bial Portugal
António Portela, CEO of Portugal’s flagship pharmaceutical company Bial, talks about the recent approval of Aptiom by the FDA, the first Portuguese drug to ever to be approved in the…
OCP Portugal is a healthcare services company, delivering pharmaceuticals to retail pharmacies as its core business.
OCP Portugal distribution supplies branded, generic and OTC pharmaceuticals and all the products that a pharmacy normally sells (dermocosmetics, medical devices, etc), being a reference of good practices and services in Portugal.
They ensure that the heath products from the pharmaceutical industry to the pharmacy are delivered under appropriate conditions. For that, all products are store in the specified conditions and their warehouses are automated to increase the efficiency in processing orders. They use the most modern procedures of pharmaceutical distribution to ensure a service with efficiency and quality.
They have established business partnerships with the pharmaceutical industry to grant an attractive offer to their customers. They adjusted their service offers to meets the needs of their partners (pharmacies and pharmaceutical industry), supporting them and providing the necessary resources to improve their business.
OCP Portugal, Produtos Farmacêuticos S.A
Rua do Barreiro 235 Crestins 4470-573 Maia Portugal
Phone: +351 229 409 400
Fax: +351 229 409 490
ocp.portugal@ocp.pt
www.ocp.pt
Warehouses: Lisbon, Oporto, Braga, Viseu, Régua, Torres Novas and Setúbal
António Portela, CEO of Portugal’s flagship pharmaceutical company Bial, talks about the recent approval of Aptiom by the FDA, the first Portuguese drug to ever to be approved in the…
Ramón Palou de Comasema, Country Director of Amgen Portugal, talks about the struggle to enter the reimbursement process in Portugal, how Amgen Portugal has broken this trend by having three…
Angelini Portugal’s Luigi Cianci offers his critique of the decline of Portugal’s economy and its effects on the industry, talking specifically about the company’s presence in Portugal and its export…
Nelson Ambrogio, managing director of Bayer Portugal, talks about tthe collaboration between the industry and the government, he recent successes of his affiliate, and strategies for continued growth during the…
Servier Portugal’s general manager José Albino Mendes discusses how Portugal’s economic crisis provides real opportunities for growth, the potential for attracting talent in innovative research, and the affiliate’s recently opened…
Nuno Brás, General Manager of LEO Farmacêuticos discusses the effect of the crisis on the Portuguese pharmaceutical market, how being a small privately owned company was an advantage during the…
David Setboun, Country President of AstraZeneca, discusses the opportunities that the Portuguese market can bring despite economic downturn, and the future of the Portuguese affiliate in expanding to new therapeutic…
Fermin Rivas Lopez, Country Manager of Celgene Portugal, gives his insight on Portugal’s recent economic problems, the challenges Celgene Portugal faces due to the economic state of the country, and…
Robin Turner, General Manager of Roche Portugal, looks back on the evolution of the affiliate, and describes how the company managed to recover its debt owed by Portuguese hospitals through…
António Leão, General Manager of Lilly, Portugal, talks about adapting to a challenging economic environment, as well as the importance of the company’s portfolio and pipeline, in Portugal today. Why…
Eduardo Pinto Leite, Director General of GSK Portugal, talks about the recent Portugal bailout, how its effects pushed GSK to some tough decision, and why he sees a brighter future…
See our Cookie Privacy Policy Here
